封面
市场调查报告书
商品编码
1464130

2024 年全球医疗仿生市场报告

Medical Biomimetics Global Market Report 2024

出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

医疗仿生学的市场规模预计在未来几年将稳定成长。到2028年,这一数字将以6.8%的年复合成长率(CAGR)增长至476.9亿美元。预计预测期内的成长将受到以下因素的推动:器官移植需求的增加、医疗保健中仿生技术应用意识的提高、医疗保健支出的增加、生物技术领域的扩大以及组织工程的进步。预测期内的主要趋势包括仿生矫正器具、仿生感测器、合成生物学应用、智慧药物传输系统、仿生机器人、个人化医疗和 3D 列印,其中包括技术、人工智慧在诊断中的应用、奈米技术的应用、以及再生医学的进展。

肥胖和心臟病发病率的预期增加预计将推动医学仿生市场的成长。肥胖症的特征是体内过多脂肪的积累,而心臟病则包括影响心臟和血管的各种疾病,这些都推动了对创新解决方案的需求。医学仿生学在矫正器具和义肢等辅助器具的开发中发挥重要作用,以帮助个人控製糖尿病和肥胖等疾病。 2022年5月,美国疾病管制与预防中心报告称,美国重度肥胖人数大幅美国,从4.7%增加到2021年的9.2%。其中,20~39岁成年人肥胖率为39.8%,40~59岁成年人肥胖率为44.3%。此外,英国国家统计局 2022 年 3 月发布的一份报告强调,心臟病相关死亡人数将从 2020 年的 19,440 人增加到 2021 年的 20,061 人。肥胖和心臟病发病率的上升是医学仿生市场的主要驱动力。

医疗仿生学领域的领先公司正在策略性地投资于具有先进技术的创新产品。特别是,缝合锚钉系统的发展是一项重要的进步。这种医疗设备用于整形外科和运动医学手术,以将肌腱和韧带等软组织固定在骨骼上。缝合锚钉系统旨在模拟和加强软组织和骨骼之间的自然结合,提供反映生理组织结合的动态优化解决方案。 2022年12月,美国跨国医疗技术公司Stryker公司宣布推出一次性缝合锚钉,采用由柠檬酸聚合物製成的合成橡胶材料Citregen製成的可吸收仿生锚钉本体,并发布了系统Citrefix。这种设计可促进受控的吸收,而不引起慢性发炎,使其成为整形外科手术应用中的宝贵工具。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球市场驱动因素与限制因素
    • 市场驱动因素
    • 市场限制因素
  • 2018-2023 年全球市场规模表现与成长
  • 全球市场规模预测与成长,2023-2028、2033

第六章 市场细分

  • 全球医疗仿生市场:按类型分類的表现与预测,2018-2023、2023-2028F、2033F
  • 心血管
  • 整形外科
  • 眼科
  • 牙科
  • 其他类型
  • 全球医疗仿生市场:按应用分類的表现与预测,2018-2023、2023-2028F、2033F
  • 创伤治疗
  • 人体组织工程
  • 药物输送
  • 其他用途
  • 全球医疗仿生市场:最终用户的表现与预测,2018-2023、2023-2028F、2033F
  • 医院
  • 专科诊所
  • 其他最终用户

第 7 章 区域/国家分析

  • 全球医疗仿生市场:区域表现与预测,2018-2023、2023-2028F、2033F
  • 全球医疗仿生市场:依国家分類的表现与预测,2018-2023、2023-2028F、2033F

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争格局及公司概况

  • 医疗仿生市场:竞争格局
  • 医疗仿生市场:公司简介
    • BASF SE
    • Bayer AG
    • Abbott Laboratories
    • Stryker Corporation
    • Zimmer Biomet Holdings Inc.

第31章 其他大型创新企业

  • Otsuka Medical Device Company Ltd.
  • LivaNova PLC
  • Ossur hf.
  • Forschungszentrum Julich GmbH
  • Biohorizons Implant Systems Inc.
  • Inventia Plc
  • Blatchford Limited
  • Keystone Dental Corporation
  • Xtant Medical Holdings Inc.
  • AVINENT Science and Technology
  • SynTouch Inc.
  • Curasan Inc.
  • CorNeat Vision Inc.
  • Hstar Technologies Co. Ltd.
  • Veryan Medical Ltd.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章前瞻性与潜力分析

第36章附录

简介目录
Product Code: r16861

Medical biomimetics involves the creation and application of innovative technologies that mimic and enhance natural physiological processes. The goal is to develop functional and biomechanically optimized solutions in the healthcare field. Medical biomimetics plays a pivotal role in the advancement of artificial organs and tissues. Additionally, it is widely used in the design of drug delivery systems that replicate biological processes, thereby enhancing the precision and efficiency of targeted medication delivery.

The primary types of medical biomimetics encompass cardiovascular, orthopedic, ophthalmology, dental, and others. Cardiovascular medical biomimetics involves the examination and application of principles inspired by nature to create innovative solutions for medical challenges related to the heart and vascular system. These applications extend to areas such as wound healing, tissue engineering, drug delivery, and more. The end-users of cardiovascular medical biomimetics include hospitals, specialty clinics, and other healthcare facilities.

The medical biomimetics market research report is one of a series of new reports from The Business Research Company that provides medical biomimetics market statistics, including medical biomimetics industry global market size, regional shares, competitors with a medical biomimetics market share, detailed medical biomimetics market segments, market trends and opportunities, and any further data you may need to thrive in the medical biomimetics industry. This medical biomimetics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The medical biomimetics market size has grown strongly in recent years. It will grow from $33.8 billion in 2023 to $36.6 billion in 2024 at a compound annual growth rate (CAGR) of 8.2%. The expansion observed in the historical period can be attributed to various factors, including the increased utilization of biomimetic materials, higher research funding, a growing aging population, and an increase in the prevalence of chronic diseases. These factors collectively contributed to the development and adoption of medical biomimetics during that period.

The medical biomimetics market size is expected to see steady growth in the next few years. It will grow to $47.69 billion in 2028 at a compound annual growth rate (CAGR) of 6.8%. The anticipated growth in the forecast period is expected to be driven by factors such as the increasing demand for organ transplants, a growing awareness of biomimetics applications in healthcare, rising healthcare expenditure, the expansion of the biotechnology sector, and advancements in tissue engineering. Key trends in the forecast period encompass bio-inspired prosthetics, biomimetic sensors, applications of synthetic biology, smart drug delivery systems, biologically inspired robotics, personalized medicine, the utilization of 3D printing technologies, artificial intelligence in diagnostics, nanotechnology applications, and developments in regenerative medicine.

The anticipated rise in obesity and heart disease rates is expected to drive the growth of the medical biomimetics market. Obesity, characterized by the accumulation of excess body fat, and heart disease, encompassing various conditions affecting the heart and blood vessels, prompt the need for innovative solutions. Medical biomimetics plays a crucial role in developing assistive devices such as orthotics and prosthetics, catering to individuals managing conditions such as diabetes or obesity. In May 2022, the Centers for Disease Control and Prevention reported a significant increase in severe obesity in the US, reaching 9.2% in 2021 from 4.7%. Notably, adults aged 20 to 39 years had an obesity prevalence of 39.8%, while those aged 40 to 59 years had a prevalence of 44.3%. Additionally, a report from the UK's Office for National Statistics in March 2022 highlighted a rise in heart disease-related deaths from 19,440 in 2020 to 20,061 in 2021. The escalating rates of obesity and heart disease are therefore key drivers of the medical biomimetics market.

Leading companies in the medical biomimetics sector are strategically investing in innovative products equipped with advanced technologies. Notably, the development of a suture anchor system stands out as a significant advancement. This medical device, used in orthopedic and sports medicine procedures, secures soft tissues such as tendons or ligaments to bone. Suture anchor systems aim to mimic and enhance the natural attachment of soft tissues to bone, providing a biomechanically optimized solution mirroring physiological tissue connections. In December 2022, Stryker Corporation, a US-based multinational medical technologies company, launched Citrefix, a disposable suture anchor system incorporating a resorbable biomimetic anchor body made from Citregen, an elastomeric material engineered from a citrate polymer. This design facilitates controlled resorption without inducing chronic inflammation, making it a valuable tool in orthopedic surgical applications.

In September 2021, Keystone Dental Inc., a US-based dental implant company, strengthened its position by acquiring Osteon Medical, an Australia-based company specializing in medical biomimetics. The acquisition enables Keystone Dental to enhance its product portfolio by integrating Osteon's advanced scanning technology and cloud-based ordering platform, reinforcing its commitment to innovation in the dental implant sector.

Major companies operating in the medical biomimetics market report are BASF SE, Bayer AG, Abbott Laboratories, Stryker Corporation, Zimmer Biomet Holdings Inc., Otsuka Medical Device Company Ltd., LivaNova PLC, Ossur hf., Forschungszentrum Julich GmbH, Biohorizons Implant Systems Inc., Inventia Plc, Blatchford Limited, Keystone Dental Corporation, Xtant Medical Holdings Inc., AVINENT Science and Technology, SynTouch Inc., Curasan Inc., CorNeat Vision Inc., Hstar Technologies Co. Ltd., Veryan Medical Ltd., Swedish Biomimetics 3000 ApS, Osteopore International Pte Ltd., KitoTech Medical Ltd., Vandstrom Inc.

North America was the largest region in the medical biomimetics market in 2023. The regions covered in the medical biomimetics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the medical biomimetics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The medical biomimetics market consists of sales of diagnostic tools, wound healing products, bio-inspired robotics, bioelectronic devices and regenerative medicine. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from goods and/or services sold within the specified market and geography through sales, grants, or donations in terms of currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values - that is, they are revenues generated by organizations in the specified geography within the specified market, irrespective of where they are produced. It does not include revenues from resales either further along the supply chain or as part of other products.

Medical Biomimetics Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on medical biomimetics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for medical biomimetics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The medical biomimetics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Cardiovascular; Orthopedic; Ophthalmology; Dental; Other Types
  • 2) By Application: Wound Healing; Tissue Engineering; Drug Delivery; Other Applications
  • 3) By End User: Hospitals; Specialty Clinics; Other End Users
  • Companies Mentioned: BASF SE; Bayer AG; Abbott Laboratories; Stryker Corporation; Zimmer Biomet Holdings Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Medical Biomimetics Market Characteristics

3. Medical Biomimetics Market Trends And Strategies

4. Medical Biomimetics Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Medical Biomimetics Market Size and Growth

  • 5.1. Global Medical Biomimetics Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Medical Biomimetics Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Medical Biomimetics Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Medical Biomimetics Market Segmentation

  • 6.1. Global Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cardiovascular
  • Orthopedic
  • Ophthalmology
  • Dental
  • Other Types
  • 6.2. Global Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Wound Healing
  • Tissue Engineering
  • Drug Delivery
  • Other Applications
  • 6.3. Global Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Specialty Clinics
  • Other End Users

7. Medical Biomimetics Market Regional And Country Analysis

  • 7.1. Global Medical Biomimetics Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Medical Biomimetics Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Medical Biomimetics Market

  • 8.1. Asia-Pacific Medical Biomimetics Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Medical Biomimetics Market

  • 9.1. China Medical Biomimetics Market Overview
  • 9.2. China Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Medical Biomimetics Market

  • 10.1. India Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Medical Biomimetics Market

  • 11.1. Japan Medical Biomimetics Market Overview
  • 11.2. Japan Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Medical Biomimetics Market

  • 12.1. Australia Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Medical Biomimetics Market

  • 13.1. Indonesia Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Medical Biomimetics Market

  • 14.1. South Korea Medical Biomimetics Market Overview
  • 14.2. South Korea Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Medical Biomimetics Market

  • 15.1. Western Europe Medical Biomimetics Market Overview
  • 15.2. Western Europe Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Medical Biomimetics Market

  • 16.1. UK Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Medical Biomimetics Market

  • 17.1. Germany Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Medical Biomimetics Market

  • 18.1. France Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Medical Biomimetics Market

  • 19.1. Italy Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Medical Biomimetics Market

  • 20.1. Spain Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Medical Biomimetics Market

  • 21.1. Eastern Europe Medical Biomimetics Market Overview
  • 21.2. Eastern Europe Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Medical Biomimetics Market

  • 22.1. Russia Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Medical Biomimetics Market

  • 23.1. North America Medical Biomimetics Market Overview
  • 23.2. North America Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Medical Biomimetics Market

  • 24.1. USA Medical Biomimetics Market Overview
  • 24.2. USA Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Medical Biomimetics Market

  • 25.1. Canada Medical Biomimetics Market Overview
  • 25.2. Canada Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Medical Biomimetics Market

  • 26.1. South America Medical Biomimetics Market Overview
  • 26.2. South America Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Medical Biomimetics Market

  • 27.1. Brazil Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Medical Biomimetics Market

  • 28.1. Middle East Medical Biomimetics Market Overview
  • 28.2. Middle East Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Medical Biomimetics Market

  • 29.1. Africa Medical Biomimetics Market Overview
  • 29.2. Africa Medical Biomimetics Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Medical Biomimetics Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Medical Biomimetics Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Medical Biomimetics Market Competitive Landscape And Company Profiles

  • 30.1. Medical Biomimetics Market Competitive Landscape
  • 30.2. Medical Biomimetics Market Company Profiles
    • 30.2.1. BASF SE
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Bayer AG
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Abbott Laboratories
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Stryker Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Zimmer Biomet Holdings Inc.
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Medical Biomimetics Market Other Major And Innovative Companies

  • 31.1. Otsuka Medical Device Company Ltd.
  • 31.2. LivaNova PLC
  • 31.3. Ossur hf.
  • 31.4. Forschungszentrum Julich GmbH
  • 31.5. Biohorizons Implant Systems Inc.
  • 31.6. Inventia Plc
  • 31.7. Blatchford Limited
  • 31.8. Keystone Dental Corporation
  • 31.9. Xtant Medical Holdings Inc.
  • 31.10. AVINENT Science and Technology
  • 31.11. SynTouch Inc.
  • 31.12. Curasan Inc.
  • 31.13. CorNeat Vision Inc.
  • 31.14. Hstar Technologies Co. Ltd.
  • 31.15. Veryan Medical Ltd.

32. Global Medical Biomimetics Market Competitive Benchmarking

33. Global Medical Biomimetics Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Medical Biomimetics Market

35. Medical Biomimetics Market Future Outlook and Potential Analysis

  • 35.1 Medical Biomimetics Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Medical Biomimetics Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Medical Biomimetics Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer